<DOC>
	<DOC>NCT01049165</DOC>
	<brief_summary>The primary purpose of this study is to evaluate the safety and tolerability of single oral doses of BMS-813160 in healthy subjects</brief_summary>
	<brief_title>Single Ascending Dose (BMS-813160) Study</brief_title>
	<detailed_description />
	<mesh_term>Hyperplasia</mesh_term>
	<criteria>Men and women (not of child bearing potential) ages 18 to 45 Healthy subjects as determined by no clinically significant deviation from normal in medical history, physical examination, ECGs, and clinical laboratory determinations Women of Child Bearing Potential Organ dysfunction or any clinically significant deviation from normal in medical history, physical examination, ECGs, and clinical laboratory determinations</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>February 2011</verification_date>
</DOC>